Business Standard

Glenmark Pharmaceuticals Share Price

Know More
BSENSE

1,236.15 9.65 (0.79%)

12:00 AM,14th Jun 2024

1,237.15 12.30 (1.00%)

12:00 AM,14th Jun 2024

BSE : 532296

NSE : GLENMARK

Sector : Health care

ISIN Code : INE935A01035

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 14-Jun-2024 | 12:00 AM IST

Market Cap (₹ Cr)

34,884

Turnover (₹ Cr)

0.30

Volume (Shares)

24,128

Face Value

1

52-WK High

1,240.00

52-WK High Date

14-Jun-2024

52-WK Low

620.05

52-WK Low Date

23-Jun-2023

All Time High

1,261.95

All Time High Date

21-Aug-2015

All Time Low

1.89

All Time Low Date

10-Feb-2000

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd was incorporated in November 18th 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology Respiratory and Dermatology. Its branded generics business has a significant presence in markets across emerging economies including India. The company has 14 manufact...
Read More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

34,912

EPS - TTM (₹) [S]

50.49

P/E Ratio (X) [S]

1.52

Face Value (₹) 1
Latest Dividend (%)250.00
Latest Dividend Date 18-Sep-2023
Dividend Yield (%) 0.20
Book Value Share (₹) [S]814.02
P/B Ratio (₹) [S]1.52

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
HDFC Mid-Cap Opportunities Fund (G) 835.41 71,99,597 1.28
HDFC Mid-Cap Opportunities Fund (IDCW) 835.41 71,99,597 1.28
HDFC Mid-Cap Opportunities Fund - Direct (IDCW) 835.41 71,99,597 1.28
HDFC Mid-Cap Opportunities Fund - Direct (G) 835.41 71,99,597 1.28
Aditya Birla SL Flexi Cap Fund (G) 240.64 20,73,872 1.18
Aditya Birla SL Flexi Cap Fund - Direct (G) 240.64 20,73,872 1.18
SBI Arbitrage Opportunities Fund (G) 146.97 12,66,575 0.47
SBI Arbitrage Opportunities Fund (IDCW) 146.97 12,66,575 0.47
SBI Arbitrage Opportunities Fund - Direct (IDCW) 146.97 12,66,575 0.47
SBI Arbitrage Opportunities Fund - Direct (G) 146.97 12,66,575 0.47

Load more

Research Reports

Date Broker Action Prices(₹) Report
28-May-2024Edelweiss Securities Hold 1,119
22-Nov-2022Prabhudas Lilladher Accumulate 410

Stock Strength

Today's Low/High

1,221.05

1,240.75

Week Low/High

1,182.50

1,241.00

Month Low/High

985.20

1,241.00

Year Low/High

621.80

1,241.00

All time Low/High

1.89

1,263.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week3.68%3.60%0.390.75%
1 Month22.42%22.34%5.325.62%
3 Month31.86%31.96%5.335.96%
6 Month49.26%49.23%9.1910.78%
1 Year94.02%94.08%21.7725.11%
3 Year92.21%92.15%46.5148.41%

Company Info

Company Information

Chairman / Executive Director / M D / Promoter : Glenn Saldanha

Executive Director (Corporate) : Cheryl Pinto

Executive Director & Group CFO : V S Mani

Non Executive Director : B E Saldanha

Independent Non Exe. Director : Rajesh Desai.

Independent Non Exe. Director : Devendra Raj Mehta

Independent Non Exe. Director : Bernard Munos

Independent Non Exe. Director : Brian W Tempest

Independent Non Exe. Director : Sridhar Gorthi

Independent Non Exe. Director : Sona Saira Ramasastry

Independent Non Exe. Director : Dipankar Bhattacharjee

Independent Non Exe. Director : V R Iyer

Registered Office: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road,Mumbai,Maharashtra-400026 Ph: 91-22-40189999

Email:complianceofficer@glenmarkpharma.com

URL:http://www.glenmarkpharma.com

FAQs about Glenmark Pharmaceuticals Ltd

1. What's the Glenmark Pharmaceuticals Ltd share price today?
Glenmark Pharmaceuticals Ltd share price was Rs 1,236.15 at close on 14th Jun 2024. Glenmark Pharmaceuticals Ltd share price was up by 0.79% over the previous closing price of Rs 1,226.50. Glenmark Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Glenmark Pharmaceuticals Ltd share price moved up by 22.42% on BSE
  • Last 3 Months: Glenmark Pharmaceuticals Ltd share price moved up by 31.86% on BSE
  • Last 12 Months: Glenmark Pharmaceuticals Ltd share price moved up by 94.02% on BSE
  • Last 3 Years: Glenmark Pharmaceuticals Ltd price moved up by 92.21% on BSE


2. How can I quickly analyse the performance of the Glenmark Pharmaceuticals Ltd stock?
The performance of the Glenmark Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 24.50
  • Price to book value ratio is 1.52
  • Dividend yield of 0.20
  • The EPS (trailing 12 months) of the Glenmark Pharmaceuticals Ltd stock is Rs 50.49


3. What is the market cap of Glenmark Pharmaceuticals Ltd?
Glenmark Pharmaceuticals Ltd has a market capitalisation of Rs 34,884 crore.


4. What is Glenmark Pharmaceuticals Ltd's 52-week high/low share price?
The Glenmark Pharmaceuticals Ltd’s 52-week high share price is Rs 1,240.00 and 52-week low share price is Rs 620.05.


5. Is the Glenmark Pharmaceuticals Ltd profitable?
On a consolidated basis, Glenmark Pharmaceuticals Ltd reported a profit of Rs 4,613.70 crore on a total income of Rs 8,081.40 crore for the quarter ended 2024. For the year ended Mar 2024, Glenmark Pharmaceuticals Ltd had posted a loss of Rs -1,214.27 crore on a total income of Rs 3,860.49 crore.


6. Which are Glenmark Pharmaceuticals Ltd’s peers in the Health care sector?
Glenmark Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Abbott India, Glaxosmi. Pharma, Biocon, Glenmark Pharma., Gland Pharma, Ipca Labs., Ajanta Pharma.


7. Who owns how much in Glenmark Pharmaceuticals Ltd?
Key changes to the Glenmark Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Glenmark Pharmaceuticals Ltd has gone down to 46.64 per cent as of Mar 2024 from 46.65 per cent as of Jun 2023.